Leumorphin / Enkephalin B (226-254), Prepro (Human) - I-125 Labeled
Proenkephalin A Precursor Schematic (Human)
I- Leumorphin [Prepro-Enkephalin B (226-254)] (Human)
Tyr - Gly - Gly - Phe - Leu - Arg - Arg - Gln - Phe - Lys - Val - Val - Thr - Arg - Ser - Gln - Glu - Asp - Pro - Asn - Ala - Tyr - Ser - Gly - Glu - Leu - Phe - Asp - Ala
Leumorphin [Prepro-Enkephalin B (226-254)] (Human)
Rehydrate with 1ml (minimum) of distilled water just before use. Further dilute to desired concentration using any aqueous buffer. Repeated freezing and thawing is not recommended.
-20°C or lower
Instruction for possession, Handling and Use of Radioactive Material:
This radioactive material shall only be received, acquired, possessed and used by physicians, Veterinarians and investigators in laboratories or hospitals for in-vitro laboratory tests. Its use shall not involve internal or external administration of the material and radiation therefrom to human being or animals. Its receipt, acquisition, possession, use and transfer are subject to regulations and general license requirements of the U.S. Nuclear Regulatory Commission or of a State with which the Commission has entered into an agreement of the exercise of regulatory authority.
Precautions in Handling Radioactive Material:
The user should store the by-product material, until used, in the original shipping container or in a container providing equivalent radiation protection. There should be no drinking, eating or smoking while radioactive material is being handled. Hands should be covered with gloves during and thoroughly washed after the handling of radioactive material. When handling radioactive material, do not pipette by mouth. Spills should be wiped up quickly and thoroughly, and contaminant material added to the radioactive waste matter. Persons under 18 should not be permitted to handle radioactive material or enter radioactive areas.
Radioactive waste should be disposed of in compliance with Federal, State, and local Government regulations.
THIS PACKAGE CONFORMS TO THE CONDITIONS AND LIMITATIONS SPECIFIED IN 49 CFR173.421 FOR EXPECTED RADIOACTIVE MATERIAL LIMITED QUANTITY, N.O.S. UN2910.
or click the reference tab on the top to see more articles that use this product.
Links to publications that use this peptide:
Lee et al. Leumorphin has an anti-apoptotic effect by activating epidermal growth factor receptor kinase in rat pheochromocytoma PC12 cells.
J Neurochem. 2005 Oct;95(1):56-67.
• ALL CATEGORIES
• Labeled Peptides
• Peptide Libraries
• Biomarker Array
Monday 05 June, 2023
38301024 requests since Wednesday 05 April, 2006
Copyright ę 2023